1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N0279
    Cardamonin

    豆蔻明

    Inhibitor 98.38%
    Cardamonin 是一种黄酮类化合物,并针对各种信号分子、转录因子、细胞因子和酶,可抑制 mTORNF-κBAktSTAT3Wnt/β-cateninCOX-2,其表现出抗癌、抗炎、抗微生物和抗糖尿病的活性。
    Cardamonin
  • HY-130603
    DCZ0415 Inhibitor 99.81%
    DCZ0415 是一种有效的 TRIP13 抑制剂,可损害非同源末端连接修复并抑制 NF-κB 活性。DCZ0415 在体外,体内以及在耐药性骨髓瘤患者衍生的原代细胞中诱导抗骨髓瘤活性。
    DCZ0415
  • HY-B2123
    Lactose

    乳糖

    Inhibitor ≥98.0%
    Lactose 是一种由半乳糖和葡萄糖残基组成的 β-半乳糖苷,是哺乳动物乳汁中主要的碳水化合物。Lactose 是一种常量营养素,也是宿主先天免疫反应的诱导物,具有免疫调节功能。
    Lactose
  • HY-N0298
    Stachydrine

    水苏碱

    Inhibitor ≥98.0%
    Stachydrine 是中国草本植物益母草的主要成分,用于促进血液循环和消除血瘀。Stachydrine 可抑制 NF-κB 信号通路。
    Stachydrine
  • HY-N6949
    Juglone

    胡桃醌

    Inhibitor 99.77%
    Juglone (5-Hydroxy-1,4-naphthalenedione) 是可从胡桃 Juglans regia 中提取的一种黄色染料。Juglone 通过线粒体途径诱导细胞凋亡。Juglone 具有抗菌、抗肿瘤活性。
    Juglone
  • HY-17403
    Manidipine dihydrochloride

    盐酸马尼地平

    Inhibitor 99.84%
    Manidipine dihydrochloride 是一种第三代、亲脂性、口服有效且高血管选择性的钙通道 (calcium channel) 拮抗剂 (IC50 = 2.6 nM, 于豚鼠心室细胞中) 与抗高血压剂。Manidipine 能有效降低血压,兼具提高胰岛素敏感度,肾脏保护和抗动脉粥样硬化活性。Manidipine 还发挥出由 NF-κB 介导的抗炎活性以及通过抑制钙通道对多种黄病毒和负链 RNA 病毒具备的抗病毒活性。美尼地平被广泛应用于心血管、代谢性疾病和感染的研究。
    Manidipine dihydrochloride
  • HY-N0498
    Nitidine chloride

    氯化两面针碱

    Inhibitor 99.75%
    Nitidine chloride 是从 Zanthoxylum nitidum (Roxb) DC 中分离得到一种具有抗疟疾活性的化合物。Nitidine chloride 通过多个靶点通路,发挥抗癌活性,如诱导凋亡,抑制 STAT3,DNA 拓扑异构酶 1 和 2A,ERKc-Src/FAK 相关信号通路,具有抗炎活性。Nitidine chloride 通过 MAPKNF-kB 途径抑制 LPS (HY-D1056) 诱导的炎性细胞因子的产生。
    Nitidine chloride
  • HY-N1380
    Guaiacol

    愈创木酚

    Inhibitor 99.95%
    Guaiacol 是一种酚类化合物,抑制 LPS 刺激的 COX-2 表达和 NF-κB 激活。具有抗炎活性。
    Guaiacol
  • HY-141550
    BPK-25 Inhibitor 99.92%
    BPK-25 是一种活性丙烯酰胺,通过涉及共价蛋白参与的翻译后机制促进核小体重塑和脱乙酰化 (NuRD) 复合蛋白的降解。BPK-25 通过环状二核苷酸配体 cGAMP 抑制 TMEM173 激活。
    BPK-25
  • HY-10454
    Delanzomib Inhibitor ≥98.0%
    Delanzomib (CEP-18770) 是一种强效的具有口服活性的蛋白酶体的胰凝乳蛋白酶样活性 (chymotrypsin-like activity of the proteasome) 抑制剂,IC50 为 3.8 nM。Delanzomib 抑制 NF-κB 活性,诱导癌细胞凋亡 (apoptotic),并具有很强的抗血管生成和抗癌活性。
    Delanzomib
  • HY-N8518
    Malabaricone C Inhibitor 99.61%
    Malabaricone C 是一种具有口服活性的非竞争性鞘磷脂合成酶 (SMS) 抑制剂,对 SMS 1 和 SMS 2 的 IC50 值分别为 3 μM 和 1.5 μM。Malabaricone C 降低小鼠体重增加,提高葡萄糖耐量,减少肝脏脂质积累,对高脂肪饮食诱导的脂肪肝有显著的预防作用。Malabaricone C 具有抗炎作用,发现于 Myristica cinnamomea King 的果实中。Malabaricone C 有望用于肥胖和由 T 细胞过度激活而引起的免疫性疾病的研究。
    Malabaricone C
  • HY-W145499
    Zinc Gluconate

    葡萄糖酸锌

    Inhibitor 98.2%
    Zinc Gluconate 是一种葡萄糖酸盐形式的锌补充剂,在免疫功能、伤口愈合和嗅觉等多种生理过程中发挥作用。Zinc Gluconate 在小鼠中的 LD50 为 39.6 mg/kg (尾静脉注射)。 Zinc Gluconate 可用于炎症、锌缺乏症、感冒、癌症和营养补充剂的研究。
    Zinc Gluconate
  • HY-B0185A
    Lidocaine hydrochloride

    盐酸利多卡因

    Inhibitor 99.84%
    Lidocaine (Lignocaine) hydrochloride 抑制涉及复杂电压和依赖性的钠通道 (sodium channels)。Lidocaine hydrochloride 通过调节 miR-145 表达和进一步抑制 MEK/ERKNF-κB 信号通路来减少胃癌细胞的生长,迁移和侵袭。Lidocaine 是一种酰胺衍生物,是一种研究室性心律失常的活性分子和有效的肿瘤抑制剂。
    Lidocaine hydrochloride
  • HY-116035
    Nimbolide

    印苦楝内酯

    Inhibitor 99.79%
    Nimbolide 是可以从印楝 (Azadirachta indica) 中分离得到的一种三萜化合物,具有抗癌和抗增殖活性。Nimbolide 通过抑制 NF-κBCDK4/CDK6 激酶,诱导肿瘤细胞凋亡。Nimbolide 抑制 Wnt、PI3K-Akt、MAPK 和 JAK-STAT 信号通路。
    Nimbolide
  • HY-119272
    EF24 Inhibitor 99.34%
    EF24,一种姜黄素类似物,是一种 NF-kB 抑制剂,具有很强的抗肿瘤功效和口服生物利用度。EF24 在口腔鳞状细胞癌细胞中通过抑制 MAPK/ERK 信号通路发挥抗肿瘤作用。EF24 对黑素瘤和乳腺癌细胞株均有活性,GI50 值分别为 0.7 μM 和 0.8 μM。EF24 诱导 MDA-MB-231 人乳腺癌细胞和 DU-145 人前列腺癌细胞的细胞周期阻滞和凋亡 (apoptosis)。EF24 可提高活化的 Caspase3 和 Caspase9 的水平,并降低 MEK1ERK 的磷酸化形式的表达。
    EF24
  • HY-N6727
    Gliotoxin Inhibitor 99.51%
    Gliotoxin 是一种次生代谢产物,是 A. fumigatus 分泌的最丰富的霉菌毒素,抑制巨噬细胞的吞噬作用和其他免疫细胞的免疫功能。Gliotoxin 通过阻止 IκB 降解来抑制诱导型 NF-κB 活性,从而诱导宿主细胞凋亡 (apoptosis)。 Gliotoxin 可以激活 PKA 并增加细胞内 cAMP 浓度,调节肌动蛋白细胞骨架重排以促进 A. fumigatus 内化到肺上皮细胞。Gliotoxin 也是 NOTCH2 转录激活抑制剂,可有效诱导慢性淋巴细胞白血病 (CLL) 细胞凋亡。
    Gliotoxin
  • HY-N0755
    Rhoifolin

    野漆树苷

    Activator 99.25%
    Rhoifolin 是一种黄酮糖苷,可从野洋漆分离。 Rhoifolin 通过增强脂联素分泌、胰岛素受体-β (insulin receptor-β) 的酪氨酸磷酸化和 GLUT4 易位来发挥抗糖尿病作用。Rhoifolin 通过对炎症介质的多层次调控发挥抗炎作用。Rhoifolin 通过 RANKL 诱导的 NF-κBMAPK 途径改善钛颗粒刺激的骨溶解并减弱破骨细胞生成。Rhoifolin 对多种癌细胞系也具有细胞毒性活性。
    Rhoifolin
  • HY-12220
    MM-102 Inhibitor 99.39%
    MM-102 (HMTase Inhibitor IX) 是一种具有细胞渗透性并紧密结合的 MLL1-WDR5 相互作用抑制剂 (IC50=2.4 nM)。MM-102 能特异性抑制含有 MLL1 融合蛋白的白血病细胞的生长和诱导细胞凋亡 (apoptosis),并减轻缺血再灌注损伤小鼠肾脏纤维化和炎症反应。此外,MM-102 也作为 H3K4 组蛋白甲基转移酶抑制剂来改善猪体细胞核移植 (SCNT) 胚胎发育。
    MM-102
  • HY-Y1267
    Magnesium sulfate

    硫酸镁

    Inhibitor 99.07%
    Magnesium sulfate 是一种钙拮抗剂和有效的 L 型钙通道抑制剂,也是一种宫缩抑制剂。Magnesium sulfate 具有抗炎、抗惊厥、血管舒张和神经保护的作用。Magnesium sulfate 可用于先兆子痫/子痫等疾病的研究。
    Magnesium sulfate
  • HY-152860
    Darizmetinib Activator 99.94%
    Darizmetinib 是具有口服活性,强效且选择性的有丝分裂激活蛋白激酶激酶 4 (MKK4) 抑制剂。Darizmetinib 能够增强 MKK7 和 JNK1 信号通路,从而激活转录因子 ATF2 和 ELK1,促进细胞增殖和肝脏再生。Darizmetinib 有望用于防止广泛的肿瘤肝切除术后或小肝移植后的肝功能衰竭的研究。
    Darizmetinib
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.